allogeneic hematopoietic cell transplantation
Sponsors
Stanford University, University Hospital Tuebingen, Masonic Cancer Center, University of Minnesota, Asan Medical Center
Conditions
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaLeukemiaLeukemia Acute Lymphoid Leukemia (ALL)Leukemia Acute Myeloid Leukemia (AML)Leukemia Acute Promyelocytic Leukemia (APL)Leukemia Chronic Lymphocytic Leukemia (CLL)Leukemia Chronic Myelogenous Leukemia (CML)
Phase 1
Phase 2
Unknown Phase
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
TerminatedNCT00185523
Start: 2002-05-31End: 2009-04-30Updated: 2016-06-16
Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission
NCT03337568
Start: 2017-04-01End: 2021-03-30Target: 110Updated: 2019-07-08